The purpose of this study is to better understand the effects of nicotinamide riboside supplement in overall cardiovascular health in healthy adults.
This study is a randomized, double-blind, placebo-controlled, parallel-dose clinical trial. Participants will be randomly assigned to one of three groups. Study measurements will be completed at three timepoints and intervention taken daily throughout the subject's 12 weeks of participation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
200
Active supplement.
Placebo
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Number of Participants with Reduced Endothelial Stiffness
Endothelial Peripheral Arterial Tonometry testing will be used to assess endothelial stiffness changes over study
Time frame: Baseline to End of study at 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.